News Peter Robinson 2024-05-30 Peter Robinson 2024-05-30 Enable Biosciences Secures Patent for Antibody Detection Method with Applications in Type 1 Diabetes Read More Peter Robinson 2024-05-14 Peter Robinson 2024-05-14 Advanced Screening Method for Early Detection of Type 1 Diabetes Exceeds Traditional Standards Read More Peter Robinson 2024-04-04 Peter Robinson 2024-04-04 Enable Biosciences Appoints Will Robberts as Chief Financial Officer and Secures Strategic Funding Read More Peter Robinson 2024-02-12 Peter Robinson 2024-02-12 Enable Biosciences Publishes Study Revealing ADAP Technology's Improved Accuracy in T1D Risk Prediction Read More Peter Robinson 2024-01-23 Peter Robinson 2024-01-23 Enable Biosciences Launches 'Kit to Clinics' with Rigorously Vetted ADAP Technology for Diabetes Care Read More Peter Robinson 2024-01-03 Peter Robinson 2024-01-03 Enable Biosciences Inc. Reveals Key Findings on COVID-19 Transmission from Mothers to Newborns Read More Peter Robinson 2023-12-19 Peter Robinson 2023-12-19 Enable Biosciences Receives $3M Phase IIB SBIR Award from NIDDK for Advanced T1D Testing Technology Read More Peter Robinson 2023-03-21 Peter Robinson 2023-03-21 Enable Biosciences Announces Relaunch of Website for Early Detection of Type 1 Diabetes Read More Peter Robinson 2022-11-10 Peter Robinson 2022-11-10 Enable Biosciences Participates in JDRF One Walk to Raise Funds for Type 1 Diabetes Read More Peter Robinson 2022-11-03 Peter Robinson 2022-11-03 Enable Biosciences to Co-Sponsor Paris Diabetes Conference Read More Peter Robinson 2022-10-17 Peter Robinson 2022-10-17 Enable Biosciences Joins the JDRF One Walk to Raise Funds and Awareness for Type 1 Diabetes Read More Peter Robinson 2022-10-07 Peter Robinson 2022-10-07 Enable Biosciences’ Co-founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry Read More Peter Robinson 2022-07-22 Peter Robinson 2022-07-22 Detecting immunity to different COVID variants just got a whole lot easier. And soon for Monkeypox too. Read More Peter Robinson 2022-07-07 Peter Robinson 2022-07-07 Enable Biosciences Clinical Reference Lab Receives Approval to Operate in Maryland Read More Peter Robinson 2022-06-23 Peter Robinson 2022-06-23 Enable Biosciences and California Department of Public Health Issue First Peer-Reviewed Publication from Statewide Serosurvey Read More Peter Robinson 2022-06-10 Peter Robinson 2022-06-10 Enable Biosciences, Lund University Report High-Performing Immunoassay for Type 1 Diabetes and Celiac Disease Read More Peter Robinson 2021-12-15 Peter Robinson 2021-12-15 Enable-supported CalScope Serosurvey Program Issues First Preprint Read More
Peter Robinson 2024-05-30 Peter Robinson 2024-05-30 Enable Biosciences Secures Patent for Antibody Detection Method with Applications in Type 1 Diabetes Read More
Peter Robinson 2024-05-14 Peter Robinson 2024-05-14 Advanced Screening Method for Early Detection of Type 1 Diabetes Exceeds Traditional Standards Read More
Peter Robinson 2024-04-04 Peter Robinson 2024-04-04 Enable Biosciences Appoints Will Robberts as Chief Financial Officer and Secures Strategic Funding Read More
Peter Robinson 2024-02-12 Peter Robinson 2024-02-12 Enable Biosciences Publishes Study Revealing ADAP Technology's Improved Accuracy in T1D Risk Prediction Read More
Peter Robinson 2024-01-23 Peter Robinson 2024-01-23 Enable Biosciences Launches 'Kit to Clinics' with Rigorously Vetted ADAP Technology for Diabetes Care Read More
Peter Robinson 2024-01-03 Peter Robinson 2024-01-03 Enable Biosciences Inc. Reveals Key Findings on COVID-19 Transmission from Mothers to Newborns Read More
Peter Robinson 2023-12-19 Peter Robinson 2023-12-19 Enable Biosciences Receives $3M Phase IIB SBIR Award from NIDDK for Advanced T1D Testing Technology Read More
Peter Robinson 2023-03-21 Peter Robinson 2023-03-21 Enable Biosciences Announces Relaunch of Website for Early Detection of Type 1 Diabetes Read More
Peter Robinson 2022-11-10 Peter Robinson 2022-11-10 Enable Biosciences Participates in JDRF One Walk to Raise Funds for Type 1 Diabetes Read More
Peter Robinson 2022-11-03 Peter Robinson 2022-11-03 Enable Biosciences to Co-Sponsor Paris Diabetes Conference Read More
Peter Robinson 2022-10-17 Peter Robinson 2022-10-17 Enable Biosciences Joins the JDRF One Walk to Raise Funds and Awareness for Type 1 Diabetes Read More
Peter Robinson 2022-10-07 Peter Robinson 2022-10-07 Enable Biosciences’ Co-founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry Read More
Peter Robinson 2022-07-22 Peter Robinson 2022-07-22 Detecting immunity to different COVID variants just got a whole lot easier. And soon for Monkeypox too. Read More
Peter Robinson 2022-07-07 Peter Robinson 2022-07-07 Enable Biosciences Clinical Reference Lab Receives Approval to Operate in Maryland Read More
Peter Robinson 2022-06-23 Peter Robinson 2022-06-23 Enable Biosciences and California Department of Public Health Issue First Peer-Reviewed Publication from Statewide Serosurvey Read More
Peter Robinson 2022-06-10 Peter Robinson 2022-06-10 Enable Biosciences, Lund University Report High-Performing Immunoassay for Type 1 Diabetes and Celiac Disease Read More
Peter Robinson 2021-12-15 Peter Robinson 2021-12-15 Enable-supported CalScope Serosurvey Program Issues First Preprint Read More
